Biolevox(TM) HA

Information

The Biolevox(TM) HA product family is based on hyaluronic acid with carefully selected concentration, viscosity and molecular parameters tailored to specific clinical applications. Biolevox(TM) HA ONE delivers 120 mg of highly purified HA in a single injection. Its USP is clinically confirmed OA symptom relief and improved joint function lasting up to 12 months. Biolevox(TM) HA 2.2% provides 44 mg HA in 2 ml through a 3-injection course. Its USP is versatility: it can be used in different joints and supports pain relief and mobility after arthroscopy. Biolevox(TM) HA MINI is designed for small joints, including the hand, foot, ankle and facet joints. Its USP is precise viscosupplementation that relieves pain and improves mobility for months. Biolevox(TM) HA TENDON is designed for tendinopathy and enthesopathy. Its USP is targeted anti-catabolic action that supports tendon ...
Product Categories
  • Finished Dosage Forms
    • Injectables
    • Packaging Materials and Equipment
      • Medical Devices and Medical Packaging
      Distribution Areas
      OceaniaNorth America (USA, Canada)AfricaMiddle East Region (e.g. UAE)Central America (e.g. Mexico)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)South Asia (e.g. India, Pakistan, Sri Lanka)
      Supplied From
      Poland

      Log in

      See all the content and easy-to-use features by logging in or registering!